BZ

Kanzhun (BZ)

Kanzhun Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BZ

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/07	06:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/02/28	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/02/27	18:50	GlobeNewswire Inc.	KANZHUN LIMITED to Report Fourth Quarter and FY2024 Results on March 11, 2025	NASDAQ:BZ	Kanzhun Ltd
2025/02/07	06:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/01/11	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/01/08	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/01/07	06:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2025/01/02	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/31	22:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BZ	Kanzhun Ltd
2024/12/31	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/30	20:07	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/27	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/17	20:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BZ	Kanzhun Ltd
2024/12/17	20:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BZ	Kanzhun Ltd
2024/12/17	06:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/11	20:39	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/11	19:55	GlobeNewswire Inc.	KANZHUN LIMITED Announces Third Quarter 2024 Financial Results	NASDAQ:BZ	Kanzhun Ltd
2024/12/09	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/06	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/05	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/04	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/03	20:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/12/02	20:02	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/11/29	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/11/29	17:30	GlobeNewswire Inc.	KANZHUN LIMITED to Report Third Quarter 2024 Results on December 11, 2024	NASDAQ:BZ	Kanzhun Ltd
2024/11/29	01:00	GlobeNewswire Inc.	KANZHUN LIMITED Continues Share Repurchase Program, Buying Back RMB1.4 Billion Worth of Ordinary Shares	NASDAQ:BZ	Kanzhun Ltd
2024/11/28	22:06	PR Newswire (US)	Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline	NASDAQ:BZ	Kanzhun Ltd
2024/11/27	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/11/26	20:04	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd
2024/11/22	20:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:BZ	Kanzhun Ltd